Tailong Pharmaceutical's 2024 First Quarter Report
Announcement of Resolutions of the 23rd Meeting of the 9th Board of Directors of Tailong Pharmaceutical
Tailong Pharmaceutical Announces Profit Distribution Plan for the First Quarter of 2024
Announcement of Tailong Pharmaceutical on holding a briefing on the results and cash dividends for the first quarter of 2024
Announcement of Resolutions of the 16th Meeting of the 9th Board of Supervisors of Tailong Pharmaceutical
Notice of Tailong Pharmaceutical on Convening the First Extraordinary General Meeting of Shareholders in 2024
Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders of Tailong Pharmaceutical
Legal Opinion of Henan Qianwen Law Firm on the 2023 Annual General Meeting of Shareholders of Henan Tailong Pharmaceutical Co., Ltd.
Tailong Pharmaceutical 2023 Annual General Meeting of Shareholders Meeting Materials
Announcement of Tarong Pharmaceutical\'s progress in providing guarantees to wholly-owned subsidiaries
Announcement of Tailong Pharmaceutical on holding the 2023 Annual Results Briefing
Talong Pharmaceutical's progress announcement on the repurchase of the company's shares through centralized bidding transactions
Asset evaluation report for the goodwill impairment test project formed by Henan Tailong Pharmaceutical Co., Ltd.'s acquisition of Beijing New Leading Pharmaceutical Technology Development Co., Ltd.
Tailong Pharmaceutical 2023 Internal Control Evaluation Report
Articles of Association of Tailong Pharmaceutical Co., Ltd. (Revised in March 2024)
Announcement of Tailong Pharmaceutical on the purchase of liability insurance for directors, supervisors, and senior executives
Announcement of Tailong Pharmaceutical requesting the shareholders\' meeting to authorize the board of directors to issue shares to specific targets through simple procedures
Tailong Pharmaceutical 2023 Annual Report
Tailong Pharmaceutical 2023 Financial Statement Audit Report
Board of Directors Rules of Procedure
No Data